Meprocon CMC en es it fr

Meprocon CMC Brand names, Meprocon CMC Analogs

Meprocon CMC Brand Names Mixture

  • No information avaliable

Meprocon CMC Chemical_Formula


Meprocon CMC RX_link

No information avaliable

Meprocon CMC fda sheet

Meprocon CMC msds (material safety sheet)

Meprocon CMC Synthesis Reference

No information avaliable

Meprocon CMC Molecular Weight

309.469 g/mol

Meprocon CMC Melting Point

< 25 oC

Meprocon CMC H2O Solubility

Soluble as HCl salt

Meprocon CMC State


Meprocon CMC LogP


Meprocon CMC Dosage Forms

Tablets (oral, 1 mg)

Meprocon CMC Indication

Used for the symptomatic treatment of parkinsonism.

Meprocon CMC Pharmacology

Metixene is a tertiary antimuscarinic with actions similar to those of atropine; it also has antihistaminic and direct antispasmodic properties. It is used for the symptomatic treatment of parkinsonism, including the alleviation of the extrapyramidal syndrome induced by other drugs such as phenothiazines, but, like other antimuscarinics, it is of no value against tardive dyskinesias. Metixene has been discontinued.

Meprocon CMC Absorption

Absorbed in the gastrointestinal tract following oral administration, however the extent of absorption is not known.

Meprocon CMC side effects and Toxicity

Signs of overdose include dilated and sluggish pupils, warm, dry skin, facial flushing, decreased secretions of the mouth, pharynx, nose, and bronchi, foul-smelling breath, elevated temperature, tachycardia, cardiac arrhythmias, decreased bowel sounds, urinary retention, delirium, disorientation, anxiety, hallucinations, illusions, confusion, incoherence, agitation, hyperactivity, ataxia, loss of memory, paranoia, combativeness, and seizures.

Meprocon CMC Patient Information

Meprocon CMC Organisms Affected

Humans and other mammals